Low-dose low-molecular-weight heparin (enoxaparin) is beneficial in lichen planus: a preliminary report
Authors:
- Gil YosipovitchGYGil Yosipovitch
- Michael DavidMDMichael David
- Arieh IngberAIArieh Ingber
- Liran ChorevLCLiran Chorev
- Ofer LiderOLOfer Lider
- Leora CahalonLCLeora Cahalon
- Irun R. CohenICIrun R. Cohen
- 1 April 1998
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 38 (4) , 564-568
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lymphocyte and Macrophage Subsets in Active and Inactive Lesions of Lichen PlanusThe American Journal of Dermatopathology, 1993
- Severe lichen planus clears with very low-dose cyclosporinBritish Journal of Dermatology, 1992
- Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell‐mediated immunityEuropean Journal of Immunology, 1990
- Cyclosporin A for treatment of severe lichen planusBritish Journal of Dermatology, 1990
- The association of mucocutaneous lichen planus and chronic liver diseaseOral Surgery, Oral Medicine, Oral Pathology, 1989
- Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins.Journal of Clinical Investigation, 1989
- Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrixJournal of Cellular Physiology, 1987
- Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidaseNature, 1984
- Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: Attachment, invasion, and subsequent degradation of the subendothelial extracellular matrixJournal of Cellular Physiology, 1984
- Oral lichen planusOral Surgery, Oral Medicine, Oral Pathology, 1968